University of Wisconsin Carbone Cancer Center | Strategic Alliance Partners

Latest from University of Wisconsin Carbone Cancer Center

Dr. Callander on Selecting a Frontline Treatment Strategy in Multiple Myeloma

January 22, 2021

Video

Natalie S. Callander, MD, discusses selecting a frontline treatment strategy for patients with multiple myeloma.

Multiple Myeloma: Co-Chaired by Natalie S. Callander, MD and Parameswaran Hari, MD, MRCP

January 13, 2021

Video

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of multiple myeloma.

Stage Is Set for Continued Progress in the Melanoma Clinic

November 04, 2020

Article

Unprecedented treatment advances have been made during the last decade for patients with advanced melanoma.

TNBC Advances Feature Immunotherapy, PARP Inhibitors, and ADCs

November 03, 2020

Article

Kari B. Wisinski, MD, discusses the evolving roles of immunotherapy, ADCs, and PARP inhibitors in triple negative breast cancer.

Hari Reviews Recent Data in Relapsed/Refectory Multiple Myeloma

October 22, 2020

Article

Parameswaran Hari, MD, MRCP, discusses key data that has read out in relapsed/refractory multiple myeloma, exciting agents generating excitement, and the role of minimal residual disease.

Dr. Paplomata on the Role of Tucatinib/Trastuzumab/Capecitabine in HER2+ Metastatic Breast Cancer

October 19, 2020

Video

Elisavet Paplomata, MD, discusses the role of tucatinib in combination with trastuzumab and capecitabine in HER2-positive metastatic breast cancer.